Skip to main content

Home/ Cancer/ Group items tagged 1989

Rss Feed Group items tagged

Matti Narkia

Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. - [Lancet. 19... - 0 views

  •  
    Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study.
    Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, Gorham ED.
    Lancet. 1989 Nov 18;2(8673):1176-8.
    PMID: 2572900

    Blood samples taken in 1974 in Washington County, Maryland, from 25 620 volunteers were used to investigate the relation of serum 25-hydroxyvitamin D (25-OHD) with subsequent risk of getting colon cancer. 34 cases of colon cancer diagnosed between August, 1975, and January, 1983, were matched to 67 controls by age, race, sex, and month blood was taken. Risk of colon cancer was reduced by 75% in the third quintile (27-32 ng/ml) and by 80% in the fourth quintile (33-41 ng/ml) of serum 25-OHD. Risk of getting colon cancer decreased three-fold in people with a serum 25-OHD concentration of 20 ng/ml or more. The results are consistent with a protective effect of serum 25-OHD on colon cancer.
Matti Narkia

Selenium and the immune response: 2. Enhancement of murine cytotoxic T-lymphocyte and n... - 0 views

  •  
    2:
    Selenium and the immune response: 2. Enhancement of murine cytotoxic T-lymphocyte and natural killer cell cytotoxicity in vivo.
    Petrie HT, Klassen LW, Klassen PS, O'Dell JR, Kay HD.
    J Leukoc Biol. 1989 Mar;45(3):215-20.
    PMID: 2564412
1 - 2 of 2
Showing 20 items per page